School of Medicine
Showing 1-10 of 57 Results
-
Irene Pachon Angona
Postdoctoral Research Fellow, Gastroenterology
BioI studied Pharmacy in the University of Seville, in the south of Spain. After that, I didi one first MSc in Molecular Biology, at CEA in Grenoble (France). However, I realized that I was more interested in chemistry. For this reason, I decided to specialzed in Medicinal Chemistry and Pharmaceutical Innovation with another MSc at the University Grenoble Alpes (France).
In 2019, I received my Ph.D. in Medicinal Chemistry from the University of Franche-Comté in France. My work in the laboratory of Prof. Lhassane Ismaili focused on the synthesis of multi-targeting ligands, using the Ugi and Hantzsch multicomponent reaction, to target different factors involved in Alzheimer’s disease as potential therapeutics. I joined Prof. Glenn lab at Stanford University where I am interested in the synthesis of broad-spectrum antivirals that target the host PI-kinases. -
Jagannath Padmanabhan
Postdoctoral Research Fellow, Plastic and Reconstructive Surgery
Summer Institutes Online Instructor, Stanford Pre-Collegiate Studies OperationsBioJagannath (Jagan) Padmanabhan, PhD is a postdoctoral research fellow in Dr. Geoffrey Gurtner’s laboratory in the Department of Surgery at Stanford University. He is a bioengineer by training (PhD, Yale University 2016) and his research interests lie at the interface of bioengineering, surgery and data science. In Dr. Gurtner's lab, Jagan is exploring the role of mechanical signaling in biomedical implant failure. He also contributes to the development of novel biomaterials for wound healing applications. He uses single cell sequencing, bioinformatics, bioengineering tools, small animal surgical models and clinical specimens to interrogate fibrotic events at the biomaterial-tissue interface and during wound healing.
Jagan is also passionate about science education and public engagement with science. He teaches STEM courses for high school students in collaboration with the Stanford pre-collegiate Institutes every summer. He also runs a blog for scientists, seekers and skeptics at www.sciencers.org.
Quick fact: Four languages and counting. -
David T. Paik
Instructor, Cardiovascular Institute
BioDr. David Paik is instructor working with Dr. Joseph Wu at Stanford Cardiovascular Institute. At Stanford, his focus is to utilize single-cell RNA-sequencing technology to elucidate patient-specific mechanisms of various cardiovascular diseases, characterize embryonic heart development, and optimize differentiation of iPSCs to subtypes of cardiovascular cells. Dr. Paik received his BA in Biochemistry and Molecular Biology at Boston University (2010) and PhD in Cell and Developmental Biology at Vanderbilt University (2015). At Vanderbilt, Dr. Paik investigated the endogenous cardiac repair mechanisms in the adult heart following ischemic injury such as myocardial infarction, with focus on the role of Wnt signaling pathway on coronary vessel formation and plasticity of endothelial cells during cardiac tissue repair. During his PhD training, Dr. Paik completed HHMI/VUMC Certificate Program in Molecular Medicine, where he was supervised by his clinical mentor Dr. Douglas Sawyer to interact with congestive heart failure patients and to bridge clinical sciences with basic and translational cardiovascular research. Dr. Paik is currently supported by the NIH NHLBI K99/R00 Pathway to Independence Award.
-
Feng Pan
Postdoctoral Research Fellow, Pathology
Current Research and Scholarly InterestsI intend to contribute to a better understanding of the genetic basis of cancer, with a specific focus on the role of epigenetic regulators or epigenetic marks in the pathogenesis of AML. I will also undertake basic work in defining the landscape of mammalian epigenome in both normal and malignant states, and the molecular mechanisms by which integration of all these data establish a 3D regulatory network. I am especially interested in identifying and characterizing the biological mechanisms of cancer stem cells from an epigenetic perspective through which the mechanistic and biological relevance of many epigenetic regulators will be unraveled and connected.
-
Paul Pang
Postdoctoral Research Fellow, Cardiovascular Institute
BioDr. Paul Pang is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in disease modeling, clinical genomics, precision medicine, and drug discovery. Dr. Pang received his Ph.D. in Integrative Molecular and Biomedical Sciences studying the alternative splicing of SCN5A in the heart and the effects of its misregulation in diseases such as myotonic dystrophy. During his Ph.D. training, he was a recipient of the NIH T32 and F31 NRSA Predoctoral Fellowships, Claude W. Smith Fellowship Award, and Dean's Award of Excellence among numerous presentation and travel awards from the Muscular Dystrophy Association and the American Heart Association. During his postdoctoral training, Dr. Pang has been awarded NIH T32 and F32 NRSA Postdoctoral Fellowships to investigate muscular dystrophies with a focus on personalized medicine and drug discovery.
